Remed Co (XKRX:302550) Total Liabilities : ₩31,252 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Remed Co Total Liabilities?

Remed Co's Total Liabilities for the quarter that ended in Mar. 2024 was ₩31,252 Mil.

Remed Co's quarterly Total Liabilities declined from Sep. 2023 (₩28,945.98 Mil) to Dec. 2023 (₩24,265.90 Mil) but then increased from Dec. 2023 (₩24,265.90 Mil) to Mar. 2024 (₩31,251.92 Mil).

Remed Co's annual Total Liabilities declined from Dec. 2021 (₩51,100.32 Mil) to Dec. 2022 (₩48,123.31 Mil) and declined from Dec. 2022 (₩48,123.31 Mil) to Dec. 2023 (₩24,265.90 Mil).

Remed Co Total Liabilities Historical Data

The historical data trend for Remed Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Remed Co Total Liabilities Chart

Remed Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

10,322.00

48,678.78

51,100.32

48,123.31

24,265.90

Remed Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															48,525.64	51,789.33	28,945.98	24,265.90	31,251.92

Remed Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Remed Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	16678.237	+	(2329.022	+	3910.075
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	1348.566)
	=	24,266

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	55060.329	-	30794.429
	=	24,266

Remed Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	18645.961	+	(6034.729	+	5113.7
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	1457.53)
	=	31,252

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	61594.838	-	30342.917
	=	31,252

Remed Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Remed Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Remed Co (XKRX:302550) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Remed Co Ltd (XKRX:302550) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

187 Techno 2-ro, No 301-303, Gwanpyeong-dong, Yuseong-gu, Daejeon, KOR, 34025

Website

http://www.remed.kr

Remed Co Ltd is a Korean medical equipment manufacturing company. The company is engaged in researching and developing products to treat brain disorders such as depression, anxiety, stroke and Parkin's. It has developed TMS device and is manufacturing pain therapy devices using advanced electromagnetic stimulation, shockwave (RSWT) and laser technologies. Its products offerings include Transcranial Magnetic simulator for brain, Electromagnetic simulators including Salus Talent, Salus Talent A, Salus Talent Pro, and Optimus Pro for pain therapy; and Rosetta, Salus RSWT and Optimus Pro as a part of Extracorporeal Shockwave Therapy. It also offers Electrosurgical units from REMED including ELPIS 4L, ELPIS 4, ELPIS 3, and ELPIS2.

Remed Co (XKRX:302550) Headlines

No Headlines